Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Enolase and arrestin are novel nonmyelin autoantigens in multiple sclerosis.

Forooghian F, Cheung RK, Smith WC, O'Connor P, Dosch HM.

J Clin Immunol. 2007 Jul;27(4):388-96. Epub 2007 Apr 10.

2.

Myelin basic protein-specific T lymphocyte repertoire in multiple sclerosis. Complexity of the response and dominance of nested epitopes due to recruitment of multiple T cell clones.

Meinl E, Weber F, Drexler K, Morelle C, Ott M, Saruhan-Direskeneli G, Goebels N, Ertl B, Jechart G, Giegerich G, et al.

J Clin Invest. 1993 Dec;92(6):2633-43.

3.

Neuron-specific enolase antibodies in patients with sudden acquired retinal degeneration syndrome.

Braus BK, Hauck SM, Amann B, Heinrich C, Fritsche J, Köstlin R, Deeg CA.

Vet Immunol Immunopathol. 2008 Jul 15;124(1-2):177-83. doi: 10.1016/j.vetimm.2008.02.020. Epub 2008 Mar 7.

PMID:
18405980
4.

Enolase autoantibodies and retinal function in multiple sclerosis patients.

Forooghian F, Adamus G, Sproule M, Westall C, O'Connor P.

Graefes Arch Clin Exp Ophthalmol. 2007 Aug;245(8):1077-84.

PMID:
17219105
5.

Beta-arrestin and arrestin are recognized by autoantibodies in sera from multiple sclerosis patients.

Ohguro H, Chiba S, Igarashi Y, Matsumoto H, Akino T, Palczewski K.

Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3241-5.

6.

HLA restriction and TCR usage of T lymphocytes specific for a novel candidate autoantigen, X2 MBP, in multiple sclerosis.

Voskuhl RR, Robinson ED, Segal BM, Tranquill L, Camphausen K, Albert PS, Richert JR, McFarland HF.

J Immunol. 1994 Nov 15;153(10):4834-44.

PMID:
7525716
8.

Autoreactivity to myelin antigens: myelin/oligodendrocyte glycoprotein is a prevalent autoantigen.

Diaz-Villoslada P, Shih A, Shao L, Genain CP, Hauser SL.

J Neuroimmunol. 1999 Sep 1;99(1):36-43.

PMID:
10496175
9.
11.

Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T lymphocytes specific for the S100 beta molecule, a calcium binding protein of astroglia.

Kojima K, Berger T, Lassmann H, Hinze-Selch D, Zhang Y, Gehrmann J, Reske K, Wekerle H, Linington C.

J Exp Med. 1994 Sep 1;180(3):817-29.

12.

Autoantigens and autoantibodies in multiple sclerosis.

Mirshafiey A, Kianiaslani M.

Iran J Allergy Asthma Immunol. 2013 Aug 28;12(4):292-303. Review.

13.
14.

Multiple sclerosis: comparison of the human T-cell response to S100 beta and myelin basic protein reveals parallels to rat experimental autoimmune panencephalitis.

Schmidt S, Linington C, Zipp F, Sotgiu S, de Waal Malefyt R, Wekerle H, Hohlfeld R.

Brain. 1997 Aug;120 ( Pt 8):1437-45.

PMID:
9278633
15.

T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis.

Ota K, Matsui M, Milford EL, Mackin GA, Weiner HL, Hafler DA.

Nature. 1990 Jul 12;346(6280):183-7.

PMID:
1694970
16.

Autoreactive T and B cells in nervous system diseases.

Sun JB.

Acta Neurol Scand Suppl. 1993;142:1-56.

PMID:
8382894
17.

Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients.

Valli A, Sette A, Kappos L, Oseroff C, Sidney J, Miescher G, Hochberger M, Albert ED, Adorini L.

J Clin Invest. 1993 Feb;91(2):616-28.

18.

Short-term evolution of autoreactive T cell repertoire in multiple sclerosis.

Vergelli M, Mazzanti B, Traggiai E, Biagioli T, Ballerini C, Parigi A, Konse A, Pellicanò G, Massacesi L.

J Neurosci Res. 2001 Nov 1;66(3):517-24.

PMID:
11746371
19.

Comparative analysis of antibody and cell-mediated autoimmunity to transaldolase and myelin basic protein in patients with multiple sclerosis.

Colombo E, Banki K, Tatum AH, Daucher J, Ferrante P, Murray RS, Phillips PE, Perl A.

J Clin Invest. 1997 Mar 15;99(6):1238-50.

20.

Supplemental Content

Support Center